Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular response to sedation agents in cataract surgery
IRCT20180416039326N20Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, midazolam and etomidate in cataract (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Cardiovascular response during sedation. Started Feb 2022; status: completed.
02
Drugs
dexmedetomidinemidazolametomidate
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20180416039326N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039326N20.